Trial intelligence / Profile preview

SOLAR: Short-course Radiation Therapy and Oxaliplatin-based Consolidation Chemotherapy for Locally Advanced Rectal Cancer

NCT05673772Phase 2Active, not recruiting

Sponsor
Kyungpook National University Hospital
Start
Oct 2020
Primary completion
Dec 2028
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of mFOLFOX6 in rectal cancer, sponsored by Kyungpook National University Hospital. Started Oct 2020; status: active, not recruiting.

02

Drugs

mFOLFOX6
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT05673772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05673772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call